References
- 1. Schwab CW Jr, Wu HY, Selman H, Smith GH, Snyder HM 3rd, Canning DA. Spontaneous resolution of vesicoureteral reflux: a 15-year perspective. J Urol. 2002;168(6):2594-9.10.1016/S0022-5347(05)64225-5
- 2. Tamminen-Möbius T, Brunier E, Ebel KD, Lebowitz R, Olbing H, Seppänen U, et al. Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. J Urol. 1992;148(5 Pt 2):1662-6.10.1016/S0022-5347(17)36997-5
- 3. Van der Meer JW, Gyssens IC. Quality of antimicrobial drug prescription in hospital. Clin Microbiol Infect. 2001;7 Suppl 6:12–5. PMID: 11990686.10.1046/j.1469-0691.7.s6.3.x
- 4. CDC, Antibiotic Resistance Threats in the United States, 2013 available at www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
- 5. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8):972-978. PMID:12719208.10.1001/archinte.163.8.972
- 6. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159-177. PMID: 17173212;10.1086/510393
- 7. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003; 36(11):1433-1437. PMID: 12766839.10.1086/375081
- 8. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49(8):1175-1184. doi: 10.1086/605630 PMID: 19739972.10.1086/605630
- 9. Evans HL, Lefrak SN, Lyman J, Smith RL, Chong TW, McElearney ST et al. Cost of Gram-negative resistance. Crit Care Med. 2007;35(1):89-95. PMID: 17110877.10.1097/01.CCM.0000251496.61520.75
- 10. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(2):155-164. doi: 10.1086/524891 PMID: 18171244.10.1086/524891
- 11. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2013. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: The Centre; 2014.
- 12. Fanos V, et al. Antibiotics or surgery for vesicoureteric reflux in children. Lancet. 2004;364:1720.10.1016/S0140-6736(04)17359-5
- 13. Blumenthal, I. Vesicoureteric reflux and urinary tract infection in children. Postgrad Med J. 2006;82:31.10.1136/pgmj.2005.036327256373316397077
- 14. Greenfield SP. Antibiotic prophylaxis in pediatric urology: an update. Curr Urol Rep. 2011;12:126.10.1007/s11934-010-0164-y21229337
- 15. Greenfield SP, et al. Vesicoureteral reflux: the RIVUR study and the way forward. J Urol.2008;179:405.10.1016/j.juro.2007.10.10018076937
- 16. Brandstrom P, et al. The Swedish reflux trial in children: IV. Renal damage. J Urol. 2010;184:292.
- 17. Sargent MA. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000;30:587.
- 18. Radmayr C, Bogaert G, et al. EAU-Guideliness on Paediatric Urology; 2019.
- 19. Wang HH, et al. Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis. J Urol. 2015;193:963.10.1016/j.juro.2014.08.112438026025196653
- 20. de Bessa J Jr, et al. Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux: a meta-analysis of randomized, controlled trials comparing dilated to nondilated vesicoureteral reflux. J Urol. 2015;193:1772.10.1016/j.juro.2014.10.09225817142
- 21. Hidas G, et al. Predicting the Risk of Breakthrough Urinary Tract Infections: Primary Vesicoureteral Reflux. J Urol. 2015;194:1396.10.1016/j.juro.2015.06.01926066405
- 22. Mathews R, et al. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes. Adv Chronic Kidney Dis. 2015;22:325.10.1053/j.ackd.2015.04.00226088078
- 23. Jun Nyung Lee, Keyong-Hyeon Beyon et al, Suceptibility of the Index Urinary Tract Infection to Prophilactic Antibiotics Is a Predictive Factor of Breakthrough Urinary Tract Infection in Children with Primary Vesicoureteral Reflux Receiving Continuous Antibiotic Prophylaxis, J Korean Med Sci. 2019 Jun 3;34(21):e156.10.3346/jkms.2019.34.e156654306331144480
- 24. Brandstrom P, et al. The Swedish reflux trial in children: IV. Renal damage. J Urol. 2010;184:292.
- 25. Hoberman A, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370:2367.10.1056/NEJMoa1401811413731924795142
- 26. Garin EH, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics. 2006;117:626.10.1542/peds.2005-136216510640
- 27. Montini G, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics. 2008;122:1064.10.1542/peds.2007-377018977988
- 28. Pennesi M, et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics. 2008;121:e1489.10.1542/peds.2007-265218490378
- 29. Roussey-Kesler, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol. 2008;179:674.10.1016/j.juro.2007.09.09018082208
- 30. Nelson CP, Hoberman A, Shaikh N, Keren R, Mathews R, Greenfield SP, et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics. 2016;137(4):e20152490.10.1542/peds.2015-2490481131126969273
- 31. Tsutomu Anraku, Kenji Obara et al, Retrospective Analysis to Determine the Optimal Timing to Discotinue Continuous Antibiotic Prophylaxis in Patient with Primary Vesicoureteral Reflux, Uro Int March 27, 2019, DOI 10.1159/000497312.10.1159/00049731230917379
- 32. Craig JC, Simpson JM, Williams GJ, Lowe A, Reynolds GJ, McTaggart SJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med. 2009;361(18):1748-59.10.1056/NEJMoa090229519864673
- 33. Wang HH, Gbadegesin RA, Foreman JW, Nagaraj SK, Wigfall DR et al. Efficacy of antibiotic prophylaxis in children with vesicoureteral reflux: systematic review and meta-analysis. J Urol. 2015;193(3):963-9.10.1016/j.juro.2014.08.112438026025196653
- 34. Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014;370(25):2367-76.10.1056/NEJMoa1401811413731924795142
- 35. Williams G, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews 2019, Issue 4. Art. No.: CD001534. DOI: 10.1002/14651858.CD001534.pub4.10.1002/14651858.CD001534.pub4644202230932167
- 36. Inouye A, Urologic Conditions in Infants and Children: Urinary Tract Infection and Vesicoureteral Reflux, LewisGale Medical Center Family Medicine Residency Program, VA24153, USA, FP Essent; 2020 Jan;488:25-34.